RecruitingNot ApplicableNCT05864274

Improve Cancer-related Cognitive Impairment

Using a Novel Mobile Cognitive Training Application to Improve Cancer-related Cognitive Impairment in Gynecologic Oncology Patients


Sponsor

University of Alabama at Birmingham

Enrollment

64 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a brain-training app on a smartphone or tablet can help women receiving chemotherapy for gynecologic cancers (uterine, ovarian, cervical, and others) manage "chemo brain" — the memory and concentration difficulties that often come with cancer treatment. **You may be eligible if...** - You are over 21 years old - You have been newly diagnosed with a gynecologic cancer (uterus, cervix, ovary, fallopian tube, vulva, or vagina) and are currently receiving chemotherapy - You own a smartphone or tablet and are able to download a cognitive training app **You may NOT be eligible if...** - You have a medical diagnosis of dementia - You are currently taking more than one medication for a significant mental health condition (single-agent treatment for depression or anxiety is okay) - You are under 21 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECognitive training application

Patients will participate with a cognitive training application and undergo neurocognitive testing during and after chemotherapy.


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05864274


Related Trials